Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure

Identifieur interne : 001D49 ( PascalFrancis/Corpus ); précédent : 001D48; suivant : 001D50

Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure

Auteurs : Atul Pathak ; Maryse Lapeyre-Mestre ; Jean-Louis Montastruc ; Jean-Michel Senard

Source :

RBID : Pascal:05-0492944

Descripteurs français

English descriptors

Abstract

We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 20
A06       @2 9
A08 01  1  ENG  @1 Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
A11 01  1    @1 PATHAK (Atul)
A11 02  1    @1 LAPEYRE-MESTRE (Maryse)
A11 03  1    @1 MONTASTRUC (Jean-Louis)
A11 04  1    @1 SENARD (Jean-Michel)
A14 01      @1 Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine @2 Toulouse @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.
A14 02      @1 Club d'Etude du Système Nerveux Autonome, Faculté de Médecine @2 Toulouse @3 FRA @Z 1 aut. @Z 4 aut.
A20       @1 1213-1219
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000131936030210
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 35 ref.
A47 01  1    @0 05-0492944
A60       @1 P @3 CC
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.
C02 01  X    @0 002B17
C02 02  X    @0 002B17F
C02 03  X    @0 002B16B
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Système nerveux autonome pathologie @5 02
C03 02  X  ENG  @0 Diseases of the autonomic nervous system @5 02
C03 02  X  SPA  @0 Sistema nervioso autónomo patología @5 02
C03 03  X  FRE  @0 Morbidité @5 09
C03 03  X  ENG  @0 Morbidity @5 09
C03 03  X  SPA  @0 Morbilidad @5 09
C03 04  X  FRE  @0 Homme @5 10
C03 04  X  ENG  @0 Human @5 10
C03 04  X  SPA  @0 Hombre @5 10
C03 05  X  FRE  @0 Complication @5 11
C03 05  X  ENG  @0 Complication @5 11
C03 05  X  SPA  @0 Complicación @5 11
N21       @1 346
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 05-0492944 INIST
ET : Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
AU : PATHAK (Atul); LAPEYRE-MESTRE (Maryse); MONTASTRUC (Jean-Louis); SENARD (Jean-Michel)
AF : Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine/Toulouse/France (1 aut., 2 aut., 3 aut., 4 aut.); Club d'Etude du Système Nerveux Autonome, Faculté de Médecine/Toulouse/France (1 aut., 4 aut.)
DT : Publication en série; Courte communication, note brève; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 9; Pp. 1213-1219; Bibl. 35 ref.
LA : Anglais
EA : We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.
CC : 002B17; 002B17F; 002B16B
FD : Système nerveux pathologie; Système nerveux autonome pathologie; Morbidité; Homme; Complication
ED : Nervous system diseases; Diseases of the autonomic nervous system; Morbidity; Human; Complication
SD : Sistema nervioso patología; Sistema nervioso autónomo patología; Morbilidad; Hombre; Complicación
LO : INIST-20953.354000131936030210
ID : 05-0492944

Links to Exploration step

Pascal:05-0492944

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure</title>
<author>
<name sortKey="Pathak, Atul" sort="Pathak, Atul" uniqKey="Pathak A" first="Atul" last="Pathak">Atul Pathak</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Club d'Etude du Système Nerveux Autonome, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapeyre Mestre, Maryse" sort="Lapeyre Mestre, Maryse" uniqKey="Lapeyre Mestre M" first="Maryse" last="Lapeyre-Mestre">Maryse Lapeyre-Mestre</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Senard, Jean Michel" sort="Senard, Jean Michel" uniqKey="Senard J" first="Jean-Michel" last="Senard">Jean-Michel Senard</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Club d'Etude du Système Nerveux Autonome, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0492944</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0492944 INIST</idno>
<idno type="RBID">Pascal:05-0492944</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D49</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure</title>
<author>
<name sortKey="Pathak, Atul" sort="Pathak, Atul" uniqKey="Pathak A" first="Atul" last="Pathak">Atul Pathak</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Club d'Etude du Système Nerveux Autonome, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapeyre Mestre, Maryse" sort="Lapeyre Mestre, Maryse" uniqKey="Lapeyre Mestre M" first="Maryse" last="Lapeyre-Mestre">Maryse Lapeyre-Mestre</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Senard, Jean Michel" sort="Senard, Jean Michel" uniqKey="Senard J" first="Jean-Michel" last="Senard">Jean-Michel Senard</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Club d'Etude du Système Nerveux Autonome, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Complication</term>
<term>Diseases of the autonomic nervous system</term>
<term>Human</term>
<term>Morbidity</term>
<term>Nervous system diseases</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Système nerveux autonome pathologie</term>
<term>Morbidité</term>
<term>Homme</term>
<term>Complication</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>20</s2>
</fA05>
<fA06>
<s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PATHAK (Atul)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LAPEYRE-MESTRE (Maryse)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MONTASTRUC (Jean-Louis)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>SENARD (Jean-Michel)</s1>
</fA11>
<fA14 i1="01">
<s1>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Club d'Etude du Système Nerveux Autonome, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>1213-1219</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000131936030210</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0492944</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17F</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B16B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Système nerveux autonome pathologie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Diseases of the autonomic nervous system</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso autónomo patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Morbidité</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Morbidity</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Morbilidad</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Complicación</s0>
<s5>11</s5>
</fC03>
<fN21>
<s1>346</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 05-0492944 INIST</NO>
<ET>Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure</ET>
<AU>PATHAK (Atul); LAPEYRE-MESTRE (Maryse); MONTASTRUC (Jean-Louis); SENARD (Jean-Michel)</AU>
<AF>Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine/Toulouse/France (1 aut., 2 aut., 3 aut., 4 aut.); Club d'Etude du Système Nerveux Autonome, Faculté de Médecine/Toulouse/France (1 aut., 4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 9; Pp. 1213-1219; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<EA>We investigated the effects of high-external-temperature exposure on neurogenic orthostatic hypotension (OH). Thirty-one patients with autonomic failure (AF) and pharmacologically treated OH related to probable multiple-system atrophy (n = 7), Parkinson's disease (n = 10), pure autonomic failure (n = 7), and diffuse Lewy body disease (n = 7) and 26 parkinsonians without AF were included. Prevalence and severity of clinical events were studied during the August 2003 heat wave and the 2004 summer. The prevalence of OH-related events was significantly higher in 2003 [45.1 vs. 11.5%; P = 0.0052; OR = 6.31 (1.35-33.53)] and 2004 [42.3 vs. 12.0%; P = 0.014; OR = 5.40 (1.28-22.68)] in AF than in controls. The mean severity score for clinical events was significantly higher in AF than in controls during 2003 heat wave (1.2 ± 1.4 vs. 0.2 ± 0.5) but similar in summer 2004 (0.7 ± 1.0 vs. 0.1 ± 0.3). Severe events (unusual home care, assistance, or hospitalization) were only observed in AF patients. A non-statistically significant higher prevalence of clinical events was observed in AF patients prescribed fludrocortisone (66.7%) by comparison to heptaminol (42.9%), midodrine (45.5%), or midodrine plus fludrocortisone (28.6%). This study shows that AF patients have a poor clinical outcome when exposed to high temperatures and that heat exposure is a risk factor for OH worsening.</EA>
<CC>002B17; 002B17F; 002B16B</CC>
<FD>Système nerveux pathologie; Système nerveux autonome pathologie; Morbidité; Homme; Complication</FD>
<ED>Nervous system diseases; Diseases of the autonomic nervous system; Morbidity; Human; Complication</ED>
<SD>Sistema nervioso patología; Sistema nervioso autónomo patología; Morbilidad; Hombre; Complicación</SD>
<LO>INIST-20953.354000131936030210</LO>
<ID>05-0492944</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D49 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001D49 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0492944
   |texte=   Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024